ArticleCureus2024
Advanced Trauma Care With Tricalcium Phosphate Bone Grafts for Tibial Plateau Fractures: A Report of Three Cases.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advances in implants and biological therapies have significantly improved trauma care, offering surgeons a variety of solutions for complex cases. This study evaluates the outcomes of three patients with complex Schatzker type V tibial plateau fractures, treated with open reduction and internal fixation supplemented by tricalcium phosphate bone void filler. The surgical approach was selected based on the specific fracture pattern. Postoperative outcomes were assessed using the Oxford Knee Score (OKS), Visual Analog Scale (VAS) for pain, and EQ-5D-5L for quality of life. The results indicated high patient satisfaction (mean score of 8.67 ± 2.31) and low pain levels (mean VAS of 2.67 ± 2.31). The mean OKS was 32 (± 8.66), and the mean EQ-5D-5L VAS score was 88.33 (± 16.07). Follow-up assessments revealed a good to excellent range of motion, with no significant complications. No additional articular step-off was observed at follow-up. The study suggests that tricalcium phosphate bone grafts may be a promising biomaterial for enhancing recovery in complex tibial plateau fractures by providing mechanical support and promoting osteointegration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.